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Appendix   Contents: 
1. Data item
2. Search strategy
3. Table S1: Study Characteristics & Table S2: Study Results
4. Risk of bias evaluations
5. Lists of included & excluded records
1. Data items
We adopted the criteria listed in the Template for Intervention Description and Replication (TIDieR) 
checklist to describe the intervention [67]. Additionally, we extracted data on: first author, year, 
country and language of intervention, study design, eligibility criteria, and number of patients 
included, baseline characteristics, dropout rates, and cost effectiveness. Specific to psoriasis we 
choose the following outcomes: Psoriasis Areas and Severity Index (PASI) 75%/90% improvement, 
mean (change) PASI, NAPSI, Dermatology Life Quality Index (DLQI), Short Form-36, withdrawal due to 
adverse events (AEs) and other, study-specific efficacy outcomes. If none of the pre-specified 
outcome measure were used, we reported the outcome that was reported to be the primary 
outcome of the included study as this size of the study should have been large enough to detect a 
difference if there was one (sample size calculation). 
We extracted the mean and standard deviation for continuous outcomes, the proportion of patients 
achieving a predefined outcome for all dichotomous ones and the time of assessment as well as the 
number of patients assessed for all outcomes. 
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2. Search Strategy Medline (EBSCO)
We developed a search strategy and adapted it to seven academic databases: Medline (EBSCO), 
Psychinfo (EBSCO), CINHAL (EBSCO), Embase (1980-2017 April 04), Web of Science (Indexes=SCI-
EXPANDED, SSCI Timespan=1985-2017), CENTRAL (Wiley), Lilacs), three grey literature repositories 
(oatd.org, greylit.org, worldcat.org) and the International Clinical Trials Registry Platform (ICTRP). 
Reference lists of included studies were also screened.
Example search strategy Medline (EBSCO)
S14 S13 AND S10
S13 S11 OR S12
S12 MH "Psoriasis"
S11 TI psoria* OR AB psoria*
S10 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9
S9 TI ( educat* OR motiv* OR cope OR coping OR self-manag* OR support* OR support OR program* OR intervent* 
OR instruc* )
S8 AB ( educat* OR motiv* OR cope OR coping OR self-manag* OR disease manag* OR healthy lifestyle ) N8 ( 
support* OR support OR program* OR intervent* OR instruct* )
S7 AB ( nurse N3 educat* )
S6 TI self care OR AB self care
S5 MH Self Care+ OR MH Self Help Groups+
S4 MH "Life Style" OR MH "Health Behavior"
S3 MH Health Education OR MH Patient Education as Topic OR MH
S2 TI patient education OR AB patient education 
S1 TI education* program* OR AB education* program*
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3. Table S1: Characteristics of include studies
Intervention  
First Author
Year,
Study ID
country/language Intervention THEORY-BASE PROCEDURE
WHAT 
materials were 
used
WHO 
delivered it
HOW was it 
delivered
WHERE 
was it 
delivered 
(& when)
WHEN & HOW 
OFTEN
TAILORIN
G
inclusion 
criteria 
RCT           
few, short, 1-on-1 sessions
3-months 
motivational 
interviewing 
(MI) for 
psoriasis 
patients after 
climate therapy 
(CHT)
motivational 
interviewing; 
transtheoretical 
model of change 
(TTM)  
motivational interviewing: 1st meeting : 
counsellor let patients describe how psoriasis 
affects their lives, and their thoughts on 
lifestyle choices and change - use of "shoe 
exercise" to reach focus areas for change 
skin & skin treatment were mandatory topic in 
each follow-up call, 
3 psoriasis-tailored domain (diet, physical 
activity,stress management) were introduced 
and the patient could talk about these or 
suggest others, patients could assess their 
own stage of change using the TTM, 
patients receive one motivational mapping 
session
(4560 min) and six motivational interviewing 
telephone calls (15-60 min) during the 
following 12 weeks  
workbook for 
patients with 
key MI 
principles and 
TTM, visual 
tools, 'bubble 
sheet', open 
questions, 
MI counsellor 
(1st author)
1 face to face 
mapping talk 
+ 6 x 
telephone
1 x in Gran 
Canaria, 
then via 
telephone
1 x before returning 
home (45-60mins), 
then 6 follow-up calls 
over 12w (mean 
duration 32.5±12.7 
mins)
individually 
tailored MI, 
use of TTM 
model to 
tailor 
conversatio
n to stage 
of change
20-70 
yoa, 
PASI 
>7.0
patients 
who had 
participat
ed in 3w 
CHT 
(educatio
n was 
part of 
CHT)
Larsen 2014,
Larsen 2017
(NCT01352780)
Norway, Norwegian
(data was 
confirmed/amende
d by the author)
UC after CHT (no restriction, considerable variation is to be expected)
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Topical 
Treatment 
Optimisation 
Programme
based on: 
literature review, 
national & 
international 
patient 
organisation 
focus groups, all 
items presented 
to the mixed-
expert focus 
groups, 
elements from 
change 
behaviour
theories used,
1-to-1 conversation with dermatologist re: 
pathophysiology, chronicity, comorbidity, then 
topical, systemic or photo treatment is 
discussed and topical advised, study meds 
introduced, 
1-to-1 conversation with nurse -nurse 
explains correct application, 
 nurse contacts patient on day 7 and day 21 
to remind them to apply treatment daily; 
information material given (contains short 
information about psoriasis, types and 
treatment)
telephone/email helpdesk,
reminders for using treatment
two visit 
checklist with 
instructions for 
a one-to-one 
conversation 
between 
dermatologist 
or nurse and
patient; 
the TTOP 
Patient 
Brochure; 
helpdesk for 
patients; 
treatment 
reminders, 
individualized 
pocket card
dermatologist, 
and nurse; 
same staff 
should 
manage same 
persons long-
term
face-to-face 
once by 
dermatologist
, once by 
nurse, via 
phone or 
email twice
ns
2 x face to face, 2 x 
via telephone/email
pocket card 
tailored 
after 
treatment 
regime
M 18 yoa, 
mild-to-
moderate 
psoriasis, 
PGA M 2, 
BSA <= 
10% ;
8w of 
topical 
treatment
, naïve to 
cal/BD 
gel
Reich 2017
Reich 2014
EudraCT 2011-
001697-26
NCT01587755
France, Germany, 
Italy, the 
Netherlands, Spain, 
UK
(I.Zschocke 
confirmed/amende
d data)
standard care
web-based interventions
 
Bundy 2013
Bundy 2011 
(abstract)
England,
English 
(data confirmed by 
first author)
web-based 
psoriasis-
tailored CBT 
program - 
eTIPs 
(electronic-
Targeted 
Intervention for 
Psoriasis)
cognitive - 
behavioral 
therapy (CBT)
content: management of low mood, dealing 
with anxiety, improving self-esteem, and 
understanding and coping with psoriasis. 
patients went through reading material, 
listened to patients, completed short 
assignments
Participants had to complete one module 
before progressing to others but they were 
given choice over the order of module 
completion. 
http://www.etips.org.uk/cb/
 information, 
instruction and 
skills practice 
using 
multimedia 
techniques 
(audio, video 
and text-
based 
components
online 
modules , 
(research 
team: (clinical) 
psychologists, 
dermatologists
)
online, 
patients could 
choose order 
in which to 
complete 
modules
online (this 
was a 
primary 
care 
managed 
sample) 
6 modules of CBT 
plus education; 
encouraged to 
complete 1 module 
per week
tailored 
physician
-
diagnose
d mild-to-
moderate 
psoriasis,  
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wait list controls (delayed intervention group)
multiple group sessions
 
12-week 
educational 
programme
ns
(i) education on the patients skin disease: 
definition of the different diseases, basic
pathogenetic mechanisms, clinical 
symptoms, prognosis,
and treatment of a given skin disease are 
carefully
explained., (ii) education on a healthy lifestyle 
incl. Diet (2 sessions) exercise, sleep, 
smoking, substance use, psychodermatology: 
information on structural, biological and social 
functions of
skin; specific skin disease problems such as 
xerosis, itch
and scaling are tackled (iii) application of 
stress-reducing techniques, different types of 
sport are offered, weekly yoga, mindfulness 
medication and (iv) feedback (individual after 
ca. 6 weeks and group session at the end)
a syllabus is 
offered to 
patients for all 
sessions
- 1 x session 
on education  
delivered by 
dermatologist, 
- 3 x skin care 
sessions given 
by nurse and 
pharmacist,  
- 12 sessions 
given by 
dietician, 
psychiatrist, 
philosopher, 
sport/yoga/min
dfulness 
trainer, 4. in-
group and 
individual 
feedback 2 x
group 
session, 1st 
session 
individual
Ghent 
University 
Hospital
12 weeks; 2h or 3 h 
sessions, 2 x per 
week
ns
psoriasis, 
atopic 
dermatitis
; M yoa, 
Bostoen 2012
Bostoen 2011 
(abstract)
Lambert 2011
NCT01077882
Belgium, Dutch
standard care
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PERC 
educational 
programme
ns
educational programme at day care center 
(PERC): 
(i) history taken in regard to coping at home 
and at work, socially, self-care and 
knowledge about psoriasis and treatment (ii) 
nurse identifies functional and educational 
problems, notes instructions for educational 
events and resources (iii) nurse presents 
patients to team, who develop an education 
plan (iii) educational activities are recorded in 
chart (iv) after 3 weeks of treatment, patients 
receive modified plan with questions about 
programme, reassessment after 6m and 1y
written 
modified 
version of 
functional 
interview for 
patients
nurse, then 
educational 
team
nurse 
interviews 
groups of 
patients 
(unclear what 
happened 
during the 
programme)
Dermatolog
y Service at 
Women's 
College 
Hospital,
day care
daily programme for 3 
weeks
match 
educational 
experience 
to needs 
and 
characterist
ics of 
patients
16-60 
yoa, no 
serious 
medical 
condition
s
Rothmann 1980
Canada, English
(unable to identify 
contact details) 
Dermatology Service at Women's College Hospital
self-help group
Dorothea Orem's 
Self-Care 
Theory
group instructions to  support, increase and 
to promote all aspects of self-care, 
once every 4 w, for 
12 weeks (4 
sessions)
Thongkaow (2016- 
date unclear) 
Thailand,
Thai
(no reply from 
author) 
control group
received instructions as per clinical practice 
guideline for psoriasis
ns
ns
ns ns
Short group interventions 
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nurse support
Theory and 
evidence-based 
rational for each 
component (eg: 
group sessions, 
goal setting etc) 
informed by 
Social Learning 
Theory and the 
Self-
efficacy concept 
and 
evidence from 
an 
exploratory stud
y on self-
management 
( Ersser et al 
Brit. J Derm, 
2010: 163:1044-
9)
(i) structured, nurse-led
group learning experience; (ii) supporting 
written and audiovisual
material to provide additional information and 
a relaxation
resource and (iii) Follow-up telephone 
consultation
(ii) audiovisual 
material DVD, 
workbook
(iii) nurse 
utilized script
nurse-led 
(i) group of 
max. 9 
participants, 
(ii) at home 
(iii) via 
telephone
8 health 
centres in 
England
2 hour (group 
education) session
tailored 
through 
individualiz
ed action 
planning
M 18 yoa, 
mild to 
moderate 
plaque 
psoriasis, 
use of 
topical 
therapies 
only
Ersser 2012 
England, English
(data was 
confirmed/amende
d by the author, no 
access to raw data)
usual care 
Lora 2009
Spa in Trentino, 
Italy
(data was approved 
by Paolo Gisondi; 
no access to the 
raw data) 
2-hours 
educational 
programme by 
dermatologist 
ns
received information on different aspects of 
psoriasis including genetics, mechanisms, 
precipitating factors, course of the disease, 
preventive measures, co-morbidities, daily 
care of skin and treatment options
ns
dermatologist 
(same in both 
groups)
group 
session
Comano 
Spa
1 x ns
adults, 
mild to 
severe
chronic 
plaque 
psoriasis
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2-hours 
educational 
programme by 
dermatologist 
with 
psychologist 
Received information on different aspects of 
psoriasis including genetics, mechanisms, 
precipitating factors, course of the disease, 
preventive measures, co-morbidities, daily 
care of skin and treatment options
a psychologist participated in the discussion 
to manage negative emotions and offer 
coping strategies. The patients were allowed 
to ask questions during the presentations, 
and a discussion targeting their view and 
experience of psoriasis was also offered in 
the last 30 min of each session.
dermatologist 
(same in both 
groups) + 
psychologist
1x
CCT
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duo formular 
group therapy
equilibrium 
model 
(The interface 
level on which 
interactions
between 
institutional 
health care and 
self-help/
mutual aid are 
analysed and 
elaborated)
- decrease 
illness 
behaviour, 
anxiety, stress, 
isolation 
(experiential?)
- increase 
awareness, skills 
in self-care, 
relaxation 
(educational?)
[Bremer Schulte 
1991]
"(1) experiential and somatic aspects of 
illness and health interact; (2) in the sick 
person all these aspects are interwoven. 
Somatic aspects were entered into by 
information on ointments, radiation, 
climatotherapy, and diets. Emotional aspects 
were dealt with by gradually drawing anxiety, 
depression, and shame into the conversation.  
Worries about relapses and uncertainties as 
to what did or did not play a role were given 
due attention, as were aspects such as 
shame and shyness, lack of  understanding, 
isolation, sexual relationships, increasing 
self-care, and mutual aid. In the beginning of 
the process the patients started to discuss 
their daily problems with psoriasis, 
exchanging their experiences and insights.* 
Information was given about the nature, 
probable causes, treatment, and 
possibilities of coping with the disease, 
including self-care technics and home 
treatment of the skin condition. A specific 
feature was management through relaxation 
and respiratory exercises, which were 
practiced during
each session and between the session as a 
home task by the patients and their partners 
at home."
DFGT training 
brochure
physician & 
patient, both 
trained 
together 
face-to-face, 
group 
sessions with 
7 participants 
each
Limburg 
University 
Hospital
1978-1982,
10 2-hour sessions 
over 3 months
ns
adults, 
<70 yoa, 
diagnosis 
of 
psoriasis 
by 
dermatol
ogist
Bremer Schulte 
1985
Netherlands, PACO 
project, Dutch
questionnaire 
available in Dutch
(unable to identify 
contact details)
wait -list control group
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cognitive-
behavioural 
management 
programme
biopsychosocial 
pain 
management 
programme was 
used as model
didactic teaching about medical & biological 
basis of psoriasis, treatment and its effect, 
stress reduction techniques, muscle 
relaxation training, cognitive techniques to 
teach patient to manage appraisal, 
misinterpretation, beliefs; homework
Session 1: Elucidation of implicit model of 
psoriasis; treatment rationale;
introduction to diathesis-stress model of 
illness; introduction to CBT.
° Session 2: Education about psoriasis; goal 
setting; applied relaxation training; 
introduction to ABC to stress; generation of 
model-centred goals.
° Session 3: Cognitive therapy (guided 
discovery and prejudice models); 
identification
of thinking errors; model-centred goals.
° Session 4: Treatment education; problem-
solving skills; model-centred goals.
° Session 5: Treatment education; learning 
challenging skills; assertiveness training;
model-centred goals.
° Session 6: Summary and review of 
programme; relapse prevention; model-
centred
goals.
ns
medical, 
psychological, 
and nursing 
staff - same 
staff lead each 
session
group 
session (6-8 
participants), 
psoriasis-
speciality 
clinic, Hope 
Hospital, 
Manchester
6 sessions, 2.5h 
each, over 6 weeks
individualiz
ed model-
centre red 
goals for 
homework
18-70 
yoa, 
confirmed 
psoriasis 
diagnosis 
by 
dermatol
ogist
Fortune 2002
Fortune 2004
English, UK
(author confirmed 
data, SEM are SDs 
-  discrepancies 
remain, no access 
to original data)
standard care
Pagliarello 2011
Trento, Italy,
Italian (publication 
in English)
(no reply from 
author)
empowerment- 
based 
educational 
intervention + 
balneotherapy
ns
2-hour didactic session, overview of cause, 
course and treatment options for psoriasis 
given; modifiable risk factors such as 
smoking, alcohol and obesity discussed, 
management strategies and coping 
discussed,  physician interaction and health 
care provider relationship discussed, 
CALM- care, adherence, lifestyle, motivation
brochure ns
group 
workshop
Comano 
Spa
2 hours, once ns
> 18 yoa, 
ability to 
read and 
write 
Italian
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balneotherapy only
decision -board 
based on 
literature review, 
decisions board 
was developed 
by multi-
disciplinary 
team, then 
reviewed by 
patients, then 
piloted, shared 
decision making 
model
use of a specifically designed decisions 
board during the patient-dermatologist 
appointment
decision 
board, A4 
printed on 
both sides, 
front: topical & 
phototherapy, 
back: 
systematic 
treatments; 
side-effects 
reported in 3 
columns - 3 
colours for 
frequency of 
occurrence, 
4th column 
with other info, 
for example 
number of 
session per 
week
clinician face-to-face
dermatolog
y clinic 
(Istituto 
Dermopatic
o 
dell'Immaco
late
once directly after 
consultation
ns
M 18 
years, 
having 
been to 
the clinic 
in the last 
3m 
Renzi 2006
(no reply from 
author)
Rome, Italy, Italian
control sample (time period 1)
before- after-studies
 
Burnett 2015 
(abstract)
Burnett 2016
United States, 
English
(no reply from 
author)
verbal scripted 
educational 
intervention
ns
5-minute educational intervention prepared 
by the researchers was verbally delivered 
focus on cardiometabolic comorbidities, risk 
factors, risk reduction strategies, 
printed 
handout for 
patient which 
was read out 
by the 
researcher
researcher
face-to-face, 
verbally
urban 
academic 
dermatolog
y clinic
once (5 minutes) ns
M 18 yoa, 
diagnose
d by 
dermatol
ogist, 
moderate 
(3-10%) 
to severe 
(>10% 
BSA) 
psoriasis
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29
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31
32
33
34
35
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37
38
39
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41
42
43
44
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46
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de Korte 2005
England, Ireland, 
Netherlands, Spain 
(10 centres)
(email does not 
work/unable to 
identify other 
contact)
disease 
management 
programme
n/s
Disease management program (3 face-2-face 
consultations over 2 months); Consultation I, 
week 1: Patient profile (disease & treatment 
history, disease severity, disease 
understanding, treatment adherence, daily 
activity limitations, effects on psychosocial 
functioning, coping behaviour, needs 
expectations& motivation)2. Education 
training & advice (Psoriasis, application 
techniques, disease management, 
psychological support&coping), 3. goal 
setting for coming period, 4. 4. Study 
materials to take home: Psoriasis, disease 
management, coping behaviour, Consultation 
II, week 5: 1. Progress check, 2.Education, 
training and advice, 3. Goal adjustment, if 
needed, 4. Take-home study materials; 
Consultation III, week 9: 1. Progress check, 
2. Education, training and advice, 3. Disease 
and self-management during follow-up, 4. 
Healthcare professional remains available by 
contact phone + optional follow-up
booklets, 
videotape/CD 
Rom to take 
home for 
patients;
booklet with 
checklists, 
questions, 
information for 
HCP
dermatologist, 
dermatology 
nurse
face-to-face, 
optional 
phone call
dermatolog
y office, 
medical 
centre, 
hospital or 
speciality 
hospital
3 face-to-face 
consultations over 2-
months + optional 
phone call
tailored to 
patients' 
needs
M 18 yoa, 
psoriasis 
and 
topical 
treatment 
Tucker 2017
UK, English
(author confirmed 
data)
educational 
intervention by 
pharmacists
ns
2nd appointment: PEDESI to check patient 
knowledge, SAPASI, DLQI
supplementar
y written 
information 
(unclear)
7 community 
pharmacists 
face-to-face 
in the 
pharmacy
one face-to-face, one 
face-to-face follow-up 
at 6w (appointment 
was agreed upon)
yes
M 18yoa, 
mild to 
moderate 
psoriasis, 
prescribe
d topical 
treatment
s
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Wahl 2013
Langeland 2013
Norway, Norwegian
(author confirmed 
data)
3-week climate 
therapy and 
patient 
education in 
Gran Canaria
Theory of 
salutogenesis 
(main concept: 
sense of 
coherence, 
SOC)
schedules sun exposure (80h), swimming 
and moisturizing was encouraged, 
individual and group education sessions took 
place as well as guidance and daily training - 
only some parts were mandatory
education sessions were comprised of: 
information on pathogenesis, manifestations, 
comorbidities, HRQL, treatment, activity & 
diet
n/s
dermatologist, 
nurse, 
physiotherapis
t
individual and 
group 
sessions
Centre in 
Gran 
Canaria
n/s (daily?) n/s M 20 yoa, 
bl  baseline
m- mean
m  month
n  number
n/a  not applicable
ns  not stated
yoa  years of age
w  weeks
grey /not grey cells for readability purposed, adjacent rows with the same background colour belong to the same study (only for studies with more than 1 study arm)
? - unclear
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Table S2: Results of included studies
 
Baseline 
characteristics Results
 age gender
follow-up 
time
PASI 
75 PASI DLQI medication/treatment adherence dropouts 
dropout 
due to 
AE
cost 
effectivene
ss
First Author
Year
Patien
ts (n)  
m±sd 
(years)
female 
(%) weeks n/N
mean 
(change) 
±SD; n
otherwise 
primary 
efficacy 
outcome
mean 
(change) 
±SD; n Instrument time result n/N n/N ICER
other 
outcom
es/asse
ssment
s
RCT
few, short, 1-on-1 sessions
Larsen 2014,
Larsen 2017
(NCT0135278
0)
(data was 
confirmed/ame
nded by the 
author)
86
46.16±
12.71
41
3w; 3m
6m
(after CHT)
n/a
primary 
outcome: 
SAPASI
3m: 5.15±4.04
n= 72
6m: 6.65±4.40
n=65
[between-
group 
differences
3m: -2.47 
(95%CI -3.94 
to -1.00)
6m: -2.45 
(95%CI -4.33 
to -0.56) ]
Mean 
DLQI: 
12 w: IG: 
6.45 ± 5.5; 
72, 
26w: 
7.67±5.79; 
56, 
ns at 67m 
(no data)
health risk 
change 
assessment 
(TTM adapted 
questionnaire)
3m
risk to no 
risk: 19/72
3months: 
14/86*
6months:
21/86*
n/a
ICER when 
using DLQI 
was -1779 
(dominant 
strategy, 
positive 
incremental 
effect MI)  
but no 
difference 
in QALYs 
gained 
self-
efficacy 
VAS, 
heiQ, 
BIPQ; 
PKQ, 
TTM 
questio
nnaire, 
15D
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83
46.46±
13.02
47
3m: 7.57±4.59
n=63
6m: 8.70±6.07
n=60
Mean 
DLQI: 
12 w:
8.8 ± 7.18; 
63, 
26w: 
9.27 ± 
7.14; 60
risk to no 
risk:9/62
3months: 
20/83*
6months: 
23/83*
Reich 2017
Reich 2014
EudraCT 
2011-001697-
26
NCT0158775
5
(I.Zschocke 
confirmed/ame
nded data)
893
50.9±1
5.23
43
8; 40; 64; 4-
8, 8-16 etc. 
until 56-64 
for 
consumption 
of study 
medication)
n/a
primary 
outcome: 
response rate 
PGA 0/1 after 
8w: 36.3% 
(324/893*)
mean 
change:
-2.6±3.7
n= 671 
use of 
medication in 
g per interval 
per % of BSA 
affected 
(weighted by 
study 
personnel)
patient-
reported 
number of 
days Cal/BD 
gel was 
applied
8
64
7.0±7.3
n=817
9.5±10.7
n=580
 53.5 ± 9.9
n=?
LTF/dropout 
any reasons:
w8: 55
w64:202
ns na
For IG 
only: 
Rankin
g of 
importa
nce of 
TTOP 
elemen
ts w8 & 
64:
(1) 1-2-
1 
derma, 
(2)1-2-
1 
nurse, 
(3) 
informa
tion, (4) 
helpde
sk, (5) 
remind
er
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897
51.0±1
5.4
42
PGA 0/1 after 
8w: 31.3% 
(281/897*)
mean 
change:
-2.2±3.4
n= 816 
7.8±9.7
n=807
11.3±15.7
n=563
53.5 ± 10.2
n= ?
LTF/dropout 
any reasons:
w8: 79
w64:208
web-based interventions
67
45.8±1
2..6 
(n=60)
50
primary 
outcomes 
HADS (0 to 
28): 6w: 
6.1±3.5 n= 33 
others: 
SAPASI: 6w: 
6.5±8.5 n=35;  
data for 6m 
not presented
mean: 6w:  
5.0±5.2 
n=32
no data for 
6m
26/67 
(presumably 
6w); no data 
for 6m
Bundy 2013
Bundy 2011 
(abstract)
(data confirmed 
by first author)
68
44.3±1
2.8(n=
66)
56
6w and 6m n/a
HADS: 6w: 
8.1±4.4 n=45
SAPASI: 6w : 
7.6+±6.1 n=50
mean: 6w:  
7.7±4.5, 
n=44
no data for 
6m
 n/a
15/68(presu
mably 6w); 
no data for 
6m
n/a
multiple group sessions
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Bostoen 2012
Bostoen 2011 
(abstract)
Lambert 2011
NCT0107788
2
15
bl data only for 
mixed population
3m
6m
9m
na
Reported 
data 
(changing 
baseline 
values)
3m: mean: 
6.8 (CI 4.3-
9.3) n= 9
6m: 
5.9(CI3.0-
8.9)
n=8
9m: 7.0 
(CI3.8-10.3)
n=8
skindex-29
Reported 
data: 
(changing 
baseline 
values)
mean 4.4 
(CI 1.3-
7.4)
mean 4.7
(CI 1.3-
8.0)
mean 4.0
(CI 0.6-
7.4)
patient-
assessed, 
questionnaire 
on medical 
consumption
bl
3m
6m
9m
no treatment:
4/15
3/9
2/8
3/8
6/15 (+ 1/15 
excluded 
from 
analysis)
1/29?
cost in 
euro/EQ-
5D
not 
reported 
but authors 
state that it 
was not 
significantly 
different
PDI, 
BDI, 
physica
l 
activity, 
Everyd
ay 
Proble
m 
Checkli
st, 
medical 
therapy
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14
Reported 
data 
(changing 
baseline 
values): 
3m: mean: 
8.1 (CI 5.8-
10.4)
n= 13
6m: 7.8(CI 
5.2-10.3)
n= 13
9m: 
7.0(C3.8-
1.3)
n=13
Reported 
data 
(changing 
baseline 
values)
mean 
6.48CI3.6-
9.2)
6.9(CI4.1-
9.8)
5.8(C  
I2.9-8.8)
no treatment:
0713
1/13
1/13
1/13
1/14
Rothmann 
1980
Canada, 
English
(unable to 
identify contact 
details)
62
media
n 40
48
3w
6m
1y
na
Functional 
history chart 
(coping score 
0-4, self-care  
0-5; 
knowledge 0-
4); 0 = 'best 
possible', 13= 
'worst 
possible'
6m
coping: 1.3 
(n=42)
self-care: 1.6 
(n=44)
knowledge: 
na 26/91 na
skin 
assess
ment
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1.3 (n=43)
sum: 4.2 
(n=44)
29
media
n 41
44
6m
coping: 1.8 
(n=16)
self-care: 1.9 
(n=17)
knowledge: 
2.3 (n=15)
sum: 6.0 
(n=17)
Thongkaow 
(2016- date 
unclear)
 (no reply from 
author)
20
45.7±1
3.0
(n=17)
41 12w na
(mean+SD)
5.99±5.98
n=17
self-care ability 
(mean+SD)
109.65±8.98
n=17
(Psoriasis 
Patient
Self-care 
Ability 
Questionnaire 
- unclear)
na
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20
43.8±1
1.4
(n=19)
47
(mean+SD)
7.34±10.05
n=19
105.58±8.90
n=19
Short group interventions
28
56.86±
12.67
71
final mean
1.78±1.62
n=26
final mean:
4.58±5.05
n=26
2/28 did not 
attend group 
session, 
13/28 did not 
watch the 
DVD, 
Ersser 2012 
England, 
English
(data was 
confirmed/ame
nded by the 
author, no 
access to raw 
data)
36
59.03±
13.53
45
6w na
final mean
2.82±2.20
n=33
na
final mean
3.70±3.71
n=33
 
3/36 
excluded due 
to incomplete 
information
na
study 
questio
nnaire 
on 
usefuln
ess of 
interve
ntion 
compo
nents
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61 56±16 49
Lora 2009
Spa in Trentino, 
Italy
(data was 
approved by 
Paolo Gisondi; 
no access to 
the raw data)
62 54±15 55
directly 
'post-
intervention'; 
6 m
na
study-specific 
questionnaire; 
outcomes 
reported for 
each question 
separately
na
study 
specifi
c 
questio
nnaire 
on 
satisfa
ction 
after 
interve
ntion; 
PASI 
and 
SKinde
x only 
at 
baselin
e
CCT
Bremer Schulte 
1985
Netherlands, 
PACO project, 
28 not specified 12w na  na
(1) 
illness 
behavi
our (IB) 
& 
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Dutch
questionnaire 
available in 
Dutch
(unable to 
identify contact 
details)
14 14/14?
shame 
& 
shynes
s (SS); 
(2) 
interact
ional 
skills 
(IS), 
proble
m 
solving 
in 
groups 
(PSG), 
deident
ification 
with 
skin 
(DS), 
well-
being 
(WB).
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40
42.7±1
1.6
70
6m: 
64%
6w: 
6.5±SEM4.1 
6m:
6.5±SEM4.1 
(ITT n = 40)
6w: 10/40
6m: 12/40
Fortune 2002
Fortune 2004
English, UK
(author 
confirmed data, 
SEM are SDs -  
discrepancies 
remain, no 
access to 
original data)
53
43.1±1
2.0
65
6w
6m
6m: 
23%
6w: 
8.4±SEM4.5 
(n= 42)
6m: 
8.0±SEM4.8
(n=30)
ITT n= 53
IQP, COPE, 
TAS-20, 
PSMP, HADS, 
PLSI, PDI
n/a na
6w: 11/53
6m: 23/53
ns na na
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87
54.42±
13.57
47  Pagliarello 
2011
Trento, Italy,
Italian 
(publication in 
English)
(no reply from 
author)
49
49.67±
12.55
43
12d n/a
SAPASI, 
Skindex-17 
and PEER 
was used to 
assess 
different 
outcomes but 
results were 
not reported or 
only for the 
entire patient 
population
ns
 
87 
outpati
ents + 
84 
inpatie
nts
43±13 38
knowle
dge 
(identif
y 9 of 
12 
correct 
statem
ents): 
mean 
4.1 
(range 
1-8) 
Renzi 2006
(no reply from 
author)
Rome, Italy, 
Italian
116 
outpati
ents + 
115 
inpatie
nts
45±15 32
directly after 
the 
outpatient 
visit/ 
discharge 
visit
 
patient 
attitudes and 
satisfaction 
(See table 1) - 
which 
information is 
relevant?
n/a
knowle
dge: 
mean 
3.8 
(range 
1-7) 
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before- after-studies
Burnett 2015 
(abstract)
Burnett 2016
United States, 
English
(no reply from 
author)
41
(56 in 
2nd 
public
ation)
52 
(+U5:A
L824-
81)
51 
(21-
83)
46; 46 2-3m n/a
12-item 
questionnaire 
about 
psoriasis 
comorbidity 
awareness 
and 
knowledge
[8 of 11 
questions 
were reported 
to be sign. diff. 
Comparing bl 
to 2m - but no 
adjustment for 
number of 
sign. Tests]
 10/56 none
de Korte 2005
England, 
Ireland, 
Netherlands, 
Spain (10 
centres)
(email does not 
work/unable to 
identify other 
contact)
330
43.5±1
4.5
55.6 2m n/a
Skindex-29
bl:33.6±16.5
2m: 22.7±16.2
(no primary 
outcome 
specified)
disease 
severity 
overall (1-very 
severe to 7-
clear)
bl: 3.6±1.4
2m: 5.1±1.2
n/a
4-item 
questionnaire, 
7 -point 
response 
scale (high 
scores mean 
higher levels 
of adherence)
bl,
2m
overall 
adherence: 
assessed by 
patients 
bl:5.5±1.8,n=
330 2m: 
6.8±0.7, n= 
288
by HCP 
bl:4.2±2.3,n=
330, 2m: 
6.4±1.2, 
n=288
42/330 n/s n/a EQ-5D
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Tucker 2017
UK, English
(author 
confirmed data)
47
59±17.
01
47 n/a
PEDESI
bl:17.78±4.49
6w: 
25.17±4.03, 
n=42
SAPASI
bl:11.75±8.14
6w: 7.74±7.55
n=42
bl: 
7.14±5.61 
n= 47?
6w: 
4.14±4.16 
n= 42
 5/47 n/a
Wahl 2013
Langeland 
2013
Norway, 
Norwegian
(author 
confirmed data)
254 47±12 40
3m (after 
CT)
n/a
study-specific 
questionnaire 
PKQ
bl: 24.4±7.1, 
n= 254
3m:29.3±7.1, 
n= 211
subscale of 
HeiQ available
n/a
questionnair
e response 
rate at 3m: 
211/254
(drop out 43)
no drop out 
from the 
programme
(Langeland 
49/254)
n/a  
Note: PASI90, SF-36, NAPSI were never reported
bl  baseline
m- mean
m  month
n  number
n/a  not applicable
ns  not stated
yoa  years of age
w  weeks
grey /not grey cells for readability purposed, adjacent rows with the same background colour belong to the same study (only for studies with more than 1 study arm)
? - unclear
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4. Risk of bias evaluations
 Risk of bias 2.0 
tool    
RCTs
Randomization 
process
Deviations from 
intended 
interventions
Missing outcome 
data
Measurement of 
the outcome
Selection 
of the 
reported 
result
overall
Larsen 2014, 
Larsen 2017 low some concern some concern
high (SAPASI, 
HeiQ)
some 
concern
high
Reich 2017, 
Reich 2014 low some concern some concern
low (PGA),
high (DLQI)
some 
concern
some concern / 
high
Bundy 2013, 
Bundy 2011 
(abstract)
low some concern some concern high high high
Bostoen 2012,  
Lambert 2011 low some concern high
low (PASI), high 
(DLQI)
high high
Rothmann 1980
some concern high some concern some concern low high
Thongkaow 
(2016- date 
unclear) 
some concern high some concern some concern low high
Ersser 2012
some concern some concern some concern
some concerns 
(PASI), high (DLQI)
some 
concern
some concern/ 
high
Lora 2009
some concern some concern some concern high low high
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ROBINS-I
CCTs
Bias due to 
Confounding
Bias in selection 
of participants 
into the study
Bias in 
classification of 
interventions
Bias due to 
deviations from 
intended 
interventions
Bias due 
to missing 
data
Bias in 
measurement of 
outcomes 
Bias in selection of 
the reported result
Overall bias
Bremer Schulte 
1985
moderate low NI NI serious moderate low serious
Fortune 2002, 
Fortune 2004
critical low - moderate moderate low moderate moderate / high moderate moderate
Pagliarello 2011 serious NI serious low serious serious critical serious
Renzi 2006 moderate NI NI moderate moderate moderate moderate moderate
NI  no information
ROBINS-I - Risk Of Bias In Non-randomized Studies - of Interventions
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NIH tool
Before- 
after 
studies
1. Was 
the 
study 
question 
or 
objective 
clearly 
stated?
2. Were 
eligibili
ty/sele
ction 
criteria 
for the 
study 
populat
ion 
prespe
cified 
and 
clearly 
describ
ed?
3. Were 
the 
participa
nts in the 
study 
represent
ative of 
those 
who 
would be 
eligible 
for the 
test/servi
ce/interve
ntion in 
the 
general 
or clinical 
populatio
n of 
interest?
4. Were 
all 
eligible 
particip
ants 
that met 
the 
prespec
ified 
entry 
criteria 
enrolled
?
5. Was 
the 
sample 
size 
sufficie
ntly 
large to 
provide 
confide
nce in 
the 
findings
?
6. Was the 
test/service
/interventio
n clearly 
described 
and 
delivered 
consistentl
y across 
the study 
population
?
7. Were the 
outcome 
measures 
prespecifie
d, clearly 
defined, 
valid, 
reliable, 
and 
assessed 
consistentl
y across all 
study 
participant
s?
8. Were 
the 
people 
assessin
g the 
outcomes 
blinded 
to the 
participa
nts' 
exposure
s/interven
tions?
9. Was 
the loss 
to follow-
up after 
baseline 
20% or 
less? 
Were 
those lost 
to follow-
up 
accounte
d for in 
the 
analysis?
10. Did the 
statistical 
methods 
examine 
changes in 
outcome 
measures 
from 
before to 
after the 
interventio
n? Were 
statistical 
tests done 
that 
provided p 
values for 
the pre-to-
post 
changes?
11. Were 
outcome 
measures of 
interest 
taken 
multiple 
times before 
the 
intervention 
and multiple 
times after 
the 
intervention 
(i.e., did they 
use an 
interrupted 
time-series 
design)?
12. If the 
intervention 
was 
conducted at a 
group level 
(e.g., a whole 
hospital, a 
community, 
etc.) did the 
statistical 
analysis take 
into account 
the use of 
individual-
level data to 
determine 
effects at the 
group level?
Quality 
Rating 
(Good, 
Fair, or 
Poor) 
Bonnekoh
2006, 
Werfel 
2006
y y ns ns n y n n y na n na fair
Burnett 
2015 
(abstract), 
Burnett 
2016
y y y ns n y unclear n y, y y n na poor 
de Korte 
2005
y y y unclear y y y n y, y y n n/a good
Tucker 
2017
y y y ns n n y n y y n n/a fair
Wahl 
2013, 
Langeland 
2013
y y y y y y n n y unclear n n/a fair
n- no; na  not applicable; ns  not stated; u unclear; y - yes
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5. List of Included Records 
First Author Year Title Comment
1 J. Bostoen 2012 An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial  
2 J. Bostoen 2012 An educational program for patients with psoriasis and atopic dermatitis: A prospective randomized, controlled trial
additional abstract to Bostoen 
2012
3
M. Bremer 
Schulte 1985 Group therapy of psoriasis. Duo formula group treatment (DFGT) as an example  
4 C. Bundy 2011 Managing psychological morbidity in patients with psoriasis using a novel online treatment programme: the e-TIPs study
additional abstract to Bundy 
2013
5 C. Bundy 2013
A novel, web-based, psychological intervention for people with psoriasis: the electronic Targeted Intervention for Psoriasis 
(eTIPs) study  
6 C. J. Burnett 2015 Psoriasis and cardiometabolic disease: An educational and teaching intervention on cardiometabolic risks  
7 C. J. Burnett 2016 Psoriasis and Cardiometabolic Disease: A Brief, Focused, Educational Intervention on Cardiometabolic Risks  
8 J. de Korte 2005 Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme  
9 S. J. Ersser 2012
A pilot randomized controlled trial to examine the feasibility and efficacy of an educational nursing intervention to improve self-
management practices in patients with mild-moderate psoriasis  
10 D. G. Fortune 2004 Targeting cognitive-behaviour therapy to patients' implicit model of psoriasis: Results from a patient preference controlled trial
additional paper to Fortune 
2002
11 D. G. Fortune 2002 A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy  
12 J. Lambert 2011 A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results  
13 E. Langeland 2013 Promoting sense of coherence: Salutogenesis among people with psoriasis undergoing patient education in climate therapy additional paper to Wahl 2013
14 M. H. Larsen 2014
A telephone-based motivational interviewing intervention has positive effects on psoriasis severity and self-management: a 
randomized controlled trial  
15 M. H. Larsen 2017 Cost-utility Analysis of Supported Self-management with Motivational Interviewing for Patients with Psoriasis additional paper - Larsen 2014
16 V. Lora 2009 Efficacy of a single educative intervention in patients with chronic plaque psoriasis  
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17 C. Pagliarello 2011 Effectiveness of an empowerment-based intervention for psoriasis among patients attending a medical spa  
18 K. Reich 2014
Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program 
(TTOP) additional paper - Reich 2017
19 K. Reich 2017
A Topical Treatment Optimisation Programme (TTOP) improves clinical outcome to calcipotriol/betamethasone gel in psoriasis: 
Results of the 64-week, multinational, randomized, phase IV study in 1790 patients (PSO-TOP)  
20 C. Renzi 2006 Insufficient knowledge among psoriasis patients can represent a barrier to participation in decision-making  
21
A. I. 
Rothman 1980 An educational program for psoriatic: an evaluation  
22 Thongkaow 2016 The Effectiveness of Participation in Self-Help Group on Self-Care Ability and Disease Severity Among Patients with Psoriasis
23 R. Tucker 2016
Assessing the impact of community pharmacist led educational advice on knowledge, disease severity and quality of life in 
patients with mild to moderate psoriasis  
24 A. K. Wahl 2013 Psoriasis Patients' Knowledge about the Disease and Treatments  
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List of excluded Records 
 First Author Year Title Reasons for exclusion
1 E. A. Abel 1988 Self-care in patients with psoriasis: first international Duo-Formula Group Training Workshop no (TPE) intervention evaluated
2 E. A. Abel 1990 Psoriasis patient support group and self-care efficacy as an adjunct to day care centre treatment no (TPE) intervention evaluated
3 M. Abrouk 2016 The Patient's Guide to Psoriasis Treatment. Part 3: Biologic Injectables  material/guide was not evaluated 
4 N. Balato 2013
Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients 
with psoriasis no active component
5 S. Balica 2011 [Guide for therapeutic education program in psoriasis]  no (TPE) intervention evaluated
6 B. Bohannan 2015 Education is Key to building a better world for people with psoriasis  survey
7 B. Bonnekoh 2006 [Interdisciplinary training program for adults with psoriasis: six months follow-up] no baseline assessment 
8
J. Borrás-
Blasco 2013
Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled 
syringe to the autoinjection pen not psoriasis  
9 J. Bostoen 2011
Follow-up on the effect of a patient educational programme: Early results of a prospective randomized 
controlled trial in psoriasis and atopic dermatitis. Conference: 6th International Congress on Psoriasis: From 
Gene to Clinic London United Kingdom. Conference Start: 20111201 Conference End: 20111203 no additional data
10 V. Boudewyns 2015
Influence of patient medication information format on comprehension and application of medication 
information: A randomized, controlled experiment no active component 
11
M. Bremer 
Schulte 1985 Group therapy of psoriasis. Due formula group treatment (DFGT) as an example  duplicate entry
12
M. A. Bremer 
Schulte 1991 Self-care activating support: therapeutic touch and chronic skin disease no additional information
13 J. Captain 1997 Continuing education. Psoriasis: what to tell your patients
not available in the German inter-library loan 
system 
14 A. Carlson 2016 Interventions to improve quality of life for patients with psoriasis and psoriatic arthritis
 online training for pharmacists (like CME, CPE 
credits)
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15 C. Chambers 2013
Patient satisfaction with a novel, patient-centered model for psoriasis follow-up care: Results from a 
randomized controlled trial additional abstract Chambers  
16 C. Chambers 2011 Patient-centered online management of psoriasis: A randomized controlled equivalency trial
no educational component, likely same RCT as 
Chambers 2010 
17 C. J. Chambers 2010
Evaluation of clinical outcomes of an online teledermatology model for the management of psoriasis: A 
randomized controlled trial
abstract only, no outcome data, see abstract 
Chambers 2011
18 C. J. Chambers 2012 Patient-centered online management of psoriasis: A randomized controlled equivalency trial  no educational component
19 B. Chan 2010 One-year drug retention in individuals enrolled in an etanercept patient support program abstract only, no Pso data 
20 B. C. F. Chan 2010 One-year drug retention in etanercept patient support program enrollees abstract only, no Pso data
21 A. Chisholm 2016
Evaluation of the IMPACT study practitioner training intervention: Using motivational interviewing to 
optimize self-management in psoriasis
no relevant outcomes (only impact on 
practitioners assessed)
22 A. Chisholm 2017
Motivational interviewing-based training enhances clinicians' skills and knowledge in psoriasis: findings from 
the Pso Well® study
impact of MI training for physicians assessed 
before-after training, but no evaluation of the 
impact on outcomes/patients was included
23 M. J. Cork 2011 Patient education about topical treatments  no (TPE) intervention
24 F. Cowdell 2014
A telephone-based motivational interviewing intervention has positive effects on psoriasis severity and self-
management: a randomized controlled trial no (TPE) intervention
25 F. Cowdell 2012
The Person-Centered Dermatology Self-Care Index A Tool to Measure Education and Support Needs of 
Patients With Long-term Skin Conditions  no (TPE) intervention
26 M. Dahiya 2011 Youtube as a public educational and consulting tool in dermatopathology  no (TPE) intervention
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27 V. L. Dowling 2003
A coping skills short-term psychotherapy group for psoriasis patients: Understanding and coping with the 
psychological and physical effects of psoriasis qualitative study
28 V. L. Dowling 2014
The psychological impact of Psoriasis: A review of short-term psychotherapy group participation for Psoriasis 
patients no (TPE) intervention evaluated
29 S. J. Ersser 2002 What criteria do patients use when judging the effectiveness of psoriasis management?  no (TPE) intervention evaluated
30 B. Farahnik 2016 The Patient's Guide to Psoriasis Treatment. Part 2: PUVA Phototherapy material/guide was not evaluated 
31 E. M. Farber 1985 The office visit and the self-help concept in the treatment of psoriasis no evaluation of the effectiveness
32 E. M. Farber 1984 Self-help clinic for psoriasis no evaluation of the effectiveness
33 E. M. Farber 1993 The office visit and the self-help concept in treating the patient with psoriasis: a strategy revisited no intervention assessed
34 S. R. Feldman 1994 The readability of patient education materials designed for patients with psoriasis no (TPE) intervention
35 S. R. Feldman 2017 Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence systematic review 
36 M. Ferwerda 2016 Measuring the Therapeutic Relationship in Internet-Based Interventions Pso & RA patients
37 M. Fletcher 2005 Educational website: patient information available on psoriasis  no TPE 
38 J. Fruhauf 2012
Pilot study on the acceptance of mobile teledermatology for the home monitoring of high-need patients 
with psoriasis no (TPE) intervention
39 J. Frühauf 2010 Pilot study using teledermatology to manage high-need patients with psoriasis no educational component 
40 I. H. Ginsburg 1996 Coping with psoriasis: a guide for counseling patients  no (TPE) intervention
41 D. L. Gist 2015 Impact of a Performance Improvement CME activity on the care and treatment of patients with psoriasis  no interactive component
42
R. M. 
Goldenhar 2005 The effects of a stress reduction intervention on quality of life in psoriasis patients no (TPE) intervention
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43 C. Gradwell 2000 Teaching patients to cope with psoriasis
not available in the German inter-library loan 
system
44 C. Gradwell 2002
A randomized controlled trial of nurse follow-up clinics: do they help patients and do they free up 
consultants' time?  only ~46% of patients had psoriasis
45 J. Kabat-Zinn 2003
Part II: Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in 
patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemo-therapy 
(PUVA) no (TPE) intervention
46 J. Kabat-Zinn 1998
Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in 
patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA)
 no TPE (mindfulness relaxation tapes during 
light treatment)
47 F. GT 2010
Psöriyazis V psikodrama: Stres ve stresle  W etme. = Psychodrama with psoriasis patients: Stress 
and coping no educational components
48 M. Kardorff 2006
Evaluation of primary rehabilitation outcome in a neighbourhood rehabilitation program for psoriasis 
patients. [German] retrospective data collection  
49 M. Kaur 2006
A randomized, double-blind study of a nutritional intervention in the treatment of psoriasis. Abstract P2805. 
American Academy of Dermatology 64th Annual Meeting March 3-7, 2006  no TPE intervention
50 F. A. Kerdel 2014 Highlights of the Skin Disease Education Foundation 10th Annual Psoriasis Forum INTRODUCATION  no TPE intervention 
51 F. A. Kerdel 2015 Highlights of Skin Disease Education Foundation's 11th Annual Psoriasis Forum INTRODUCTION  duplicate entry
52 F. A. Kerdel 2016 Highlights of Skin Disease Education Foundation's 12th Annual Psoriasis Forum INTODUCTION  no TPE study
53 C. Keyworth 2014 Does health message framing affect behavioural intentions in patients with psoriasis? An experimental study no (TPE) intervention
54 C. Keyworth 2014
Talking to people with psoriasis about cardiovascular disease risk factors: Techniques used in the 
practitioner-patient consultation  no TPE intervention evaluated
55 C. Keyworth 2014 Health promotion for patients with psoriasis: Examining current signposting in U.K. health centres  no TPE intervention evaluated
56 D. Kiestra 1998
Support by the psoriasis patients' association to psoriasis patients. The visiting card to the outside world. 
[Dutch]  no TPE intervention
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57 H. Kling 2012 Significant effects of patient educative training on psoriasis disease author did not respond in time 
58 H. Kling 2013 Patient training for psoriasis-evaluation of a standardized program author did not respond in time 
59 H. Kling 2014 Significant effects of patient educative training on psoriasis disease author did not respond in time 
60 A. Kotb 2012 Psoriasis day care: Impact on quality of life & patient compliance no evaluation, abstract only
61 S. C. Laffrey 1996 Social support and health promotion outcomes of adults with psoriasis  no (TPE) intervention
62 E. Langeland 2013 Mental health among people with psoriasis undergoing patient education in climate therapy  no relevant outcome
63 M. H. Larsen 2016
Cost-utility Analysis of Supported Self-management with Motivational Interviewing for Patients with 
Psoriasis  duplicate entry
64 Q. Liu 2012 Effects of psychological and behavior intervention on the outcome of patients with psoriasis [abstract]
neither contact details nor center, nor author 
could be identified
65 R. A. Logan 1988 Self help groups for patients with chronic skin diseases no intervention 
66 B. Lombardo 1988 Group support for derm patients  no (TPE) intervention
67
P. R. 
Magdalena 2012
Psoriasis-where do patients draw information about the disease and how much do they know?, Luszczyca - 
Skad pacjenci czerpia wiedze na temat choroby i ile wiedza?. [Polish, English]  no intervention evaluated
68 S. Maguire 2012 Treating psoriasis in community practice no evaluation
69
L. McCormick 
Howard 2016 National Psoriasis Foundation: a patient-centric approach to improve access to psoriatic disease treatment case report
70 J. Miniszewska 2011
Coping with the disease as a relation mediator between skin lesion severity and psychological health in 
psoriatic patients abstract only, no intervention evaluated 
71 N. C. Morrow 1984 Printed information for patients receiving PUVA therapy no active component
72 P. A. Nelson 2015 The IMPACT Programme in Psoriasis: Phase I - where we are now and future directions no intervention evaluated
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73 P. A. Nelson 2016
Development and evaluation of the IMPACT programme patient resources to increase understanding of 
psoriasis and its management: a mixed-methods feasibility study impactpsoriasis.org.uk 
74 P. A. Nelson 2014
'In someone's clinic but not in mine'--clinicians' views of supporting lifestyle behaviour change in patients 
with psoriasis: a qualitative interview study  no (TPE) intervention
75 T. V. Nguyen 2013
Compassionate care: enhancing physician-patient communication and education in dermatology: Part I: 
Patient-centered communication  no TPE intervention
76 A. M. Oostveen 2013
Development and design of a multidisciplinary training program for outpatient children and adolescents with 
psoriasis and their parents  children
77 C. Pagliarello 2010
Measuring empowerment in patients with psoriasis: the Psoriasis Empowerment Enquiry in the Routine 
Practice (PEER) questionnaire  no (TPE) intervention
78 S. N. Pathak 2014 Self-management in patients with psoriasis  no (TPE) intervention
79 F. Petermann 2000 Cognitive-behavioral education program in psoriasis. First evaluation of results. [German] children
80 K. Radley 2013 Making a difference : Nurse prescribing for patients with psoriasis in the united kingdom  no (TPE) intervention evaluated
81
G. S. 
Rasmussen 2012 Self-management in daily life with psoriasis: an integrative review of patient needs for structured education  review
82 H. L. Richards 2006 Adherence to treatment in patients with psoriasis no primary study
83 C. Riddoch 2005 The benefits of switching to nurse-led management of patients with psoriasis no (TPE) intervention 
84 D. T. Rubin 2015
Impact of abbvie's patient support program on resource costs in crohn's disease, ulcerative colitis, 
rheumatoid arthritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis  no cost data for psoriasis patients reported
85 S. Ryan 2009 Continuing education. Patient education in psoriasis  no (TPE) intervention evaluated
86 S. Scheewe 2001
Long-term efficacy of an inpatient rehabilitation with integrated patient education program for children and 
adolescents with psoriasis  children
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87 G. Schreier 2008
A mobile-phone based teledermatology system to support self-management of patients suffering from 
psoriasis  no evaluation
88 T. K. Seng 1997 Group therapy: a useful and supportive treatment for psoriasis patients no baseline assessment
89 J. D. T. d. Silva 2006 Estratégias de coping e níveis de estresse em pacientes portadores de psoríase no (TPE) intervention
90
M. 
Skarpathiotakis 2006 Specialized education for patients with psoriasis: a patient survey on its value and effectiveness
no (TPE) intervention /not before and after 
assessment
91
S. M. 
Skevington 2006
How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating 
the WHOQOL-100 no (TPE) intervention
92 G. P. Smith 2015
The readability of patient education materials designed for patients with psoriasis: what have we learned in 
20 years? no active component
93
S. Spillekom-
van Koulil 2016
A MULTIDISCIPLINARY TRAINING PROGRAM FOR OUTPATIENT CHILDREN AND ADOLESCENTS WITH 
PSORIASIS AND THEIR PARENTS: A PILOT STUDY children, 2nd paper to Van Geel 2016
94 B. Strober 2016
Impact of a patient support program on adherence and healthcare costs in patients with psoriasis and 
psoriatic arthritis  not prospectively enrolled
95 S. Tabolli 2011 The impact of writing exercises on quality of life in patients with psoriasis undergoing systemic treatments
no (TPE) intervention (additional abstract 
Tabolli 2012)
96 S. Tabolli 2012
Evaluation of the impact of writing exercises interventions on quality of life in patients with psoriasis 
undergoing systemic treatments  no TPE intervention evaluated
97 J. Tan 2012 A Patient Decision Aid for Psoriasis Based on Current Clinical Practice Guidelines  no TPE 
98 J. Tan 2014
Improved decisional conflict and preparedness for decision making using a patient decision aid for treatment 
selection in psoriasis: A pilot study  no interactive component
99
L. Tomas-
Aragones 2011 Evaluation of a psychological group intervention for patients with moderate and severe psoriasis
no results reported, intervention poorly 
described; author did not reply
100 M. A. Turner 2015 Progress in developing and implementing stepped-care psychological support for people with psoriasis  no (TPE) intervention
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101 S. van Beugen 2015
Body attention, ignorance and awareness scale: assessing relevant concepts for physical and psychological 
functioning in psoriasis  no (TPE) intervention
102
O. D. Van 
Cranenburgh 2015
A Web-based, Educational, Quality-of-life Intervention for Patients with a Chronic Skin Disease: Feasibility 
and Acceptance in Routine Dermatological Practice
 internet platform without interactive 
component, mixed patient population
103 M. J. Van Geel 2016
An outpatient multidisciplinary training programme for children and adolescents with psoriasis and their 
parents: a pilot study programme for children
104 J. Van Onselen 2014 Supporting children and young people with psoriasis...Julie Van Onselen, dermatology nurse specialist not available in the German inter-library loan
105 P. Verrier 1991 Psoriasis: Impact of information and relaxation programs. [French] study suggested but not conducted 
106 A. K. Wahl 2015 Positive changes in self-management and disease severity following climate therapy in people with psoriasis education as part of climate- therapy
107 A. K. Wahl 2016
Making robust decisions about the impact of health education programs: Psychometric evaluation of the 
Health Education Impact Questionnaire (heiQ) in diverse patient groups in Norway validation of norwegian heiQ
108 T. Werfel 2006
[The educational program for the management of psoriasis vulgaris according to the rules of the Task Force 
on Dermatological Prevention: current status]
no baseline assessment, additional paper - 
Bonnekoh 2006
109 R. Zachariae 1996 Effects of psychologic intervention on psoriasis: a preliminary report  no active component
110 S. S. Zaghloul 2004 The influence of nurse education clinics as a supplementary technique on compliance in psoriasis
see also FT Zaghloul, no TPE intervention 
evaluation, only comparison of 2 clinics
111 T. H. Zhu 2016 The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy the online material was not evaluated 
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Abstract
Psoriasis is a chronic inflammatory skin condition. Patient education may be one option to 
improve adherence and coping. The aim of this systematic review is to identify studies 
evaluating educational interventions for psoriasis patients. The review was conducted 
following the methods recommended by Cochrane. We searched seven databases, one trial 
register and three grey literature repositories. Data screening and extraction was done by 
two t reviewers independently. The risk of bias 2.0, ROBINS-I, NIH-tool were used. 
Additionally, the APEASE criteria were applied. We evaluated 16 studies. Two RCTs evaluated 
patient-practitioner or patient-nurse one-to-one interventions, one RCT assessed a web-
based intervention, three RCTs reported group interventions taking place frequently; one 
RCT reported one-off group sessions. The remaining RCT compared the health care 
professionals involved. The risk of bias rating ranged from some concerns to high. Three 
RCTs found an effect. We included 4 CCTs - one had an effect. One of 4 included before-
after-studies warrants further investigation. Despite similarities in delivery mode across the 
interventions, patients eligible and settings in which interventions were delivered differed. 
Interventions that included an individual (one-to-one) session appear successful. Two 
interventions seem suitable for adaptation using APEASE: the topical treatment program and 
motivational interviewing after climate therapy.
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Introduction
Psoriasis is a common chronic skin condition with a prevalence of 0.1% to 11% worldwide 
[1]. Patients experience symptoms such as pruritus, burning and skin lesions that can be 
painful and disfiguring. They also often experience lower health-related quality of life and 
stigma, as well as shame and worry [2]. 
The condition is characterized by frequent flare-ups that require long-term management. 
Treatment goals revolve around symptom control rather than cure [3]. The majority of 
patients with psoriasis self-manage their condition in response to fluctuating disease 
severity [4], which can involve complex topical applications, as well as systemic therapies [4]. 
Self-management is generally defined as the activities undertaken by individuals to manage 
the symptoms, treatment, physical and psychosocial consequences and lifestyle changes 
associated with living with a long-term health condition. Patients can experience barriers to 
self-management, and treatment adherence in patients with psoriasis remains problematic 
[5-7]. Patients with conflicting beliefs and higher psychological stress may be less adherent 
to treatment [8]. Age, sex and disease- and treatment-specific factors can predict adherence 
[9]. Poor adherence increases health-care costs and compromises patient safety, quality of 
life and the effectiveness of a health care system [10].
Offering people support and information tailored to their individual needs and 
circumstances so that they can confidently self-manage their condition therefore remains a 
key principle of psoriasis care guidelines [4]. Therapeutic patient education is an integral part 
of comprehensive chronic disease management (see Figure 1). Patients with psoriasis 
consistently report that they want more information about their condition and how to 
manage it effectively. A large international survey found that out of 17 support tools, 
education about treatment options, comorbidities and the disease itself was seen by 
patients as the most important and key to improving their situation [11]. 
[insert Figure 1 here]
Patient education has been identified since the 1970s as important, and reviews continue to 
show that there is an ongoing need for education [12] but that few such interventions exist 
[13-16]. We aimed to systematically and continuously identify, summarize and evaluate 
studies that assessed a therapeutic patient education intervention for patients with 
psoriasis. 
Material and methods
The protocol for this living systematic review was registered with PROSPERO 
(CRD42017060412). When choosing methods we followed the Living systematic reviews 
(LSR) series [17-19] and recommendations by the Cochrane. We consulted the PRISMA 
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checklist [20] and AMSTAR II. Every three months we screen for new studies utilizing the 
same sources and criteria. Updates are then reported on the following website: 
http://www.spindermatology.org/ 
We pre-defined the eligibility criteria [21] (Table 1).
[insert Table 1 here]
We searched seven academic and three grey literature databases and one trial registry (see 
online appendix). Where possible, we activated the autoalert function to receive alerts. 
Endnote was used to manage the records. Two reviewers (CD, MZ) independently screened 
all titles/abstracts and full-texts for eligibility. One reviewer (CD) developed and piloted a 
data extraction sheet with the research team (PG, AN, JL, LG). We used MS Excel for data 
extraction purposes (see online appendix). Two reviewers (CD, MZ) extracted the same data 
independently. Any discrepancies were resolved by discussion, if necessary involving a third 
researcher (AN). First or last authors were contacted to verify extracted data and obtain 
missing data.
We used the Cochrane risk of bias tool 2.0 [22]. Assessments were made for the domains: 
randomization process, deviations from the intended intervention, missing outcome data, 
measurement of outcome, and selection of the reported results. Each domain was rated as 
low, some concerns or high risk of bias. Overall ratings were high if either one domain 
was rated as high risk or if multiple domains were rated as some concerns. It was  some 
concerns in cases where at least one domain was rated as some concerns. 
ROBINS-I was utilized to assess non-randomized studies [23]. The seven domains are: bias 
due to confounding, in selection of participants to the study, in classification of interventions, 
due to deviations from the intended interventions, due to missing data, in measurement of 
outcomes, in selection of reported results. 
We used the US National Heart, Blood, and Lung Institute (NIH) Quality Assessment Tool for 
Before-After (Pre-Post) Studies with No Control Group for any studies of this nature included 
in our review [24]. However, we modified question number 10 of the tool so that it expected 
comprehensive statistical reporting rather than p-values alone (see Online Appendix). 
We calculated effect measures such as risk ratios (RR) or mean differences (MD) and 95% 
confidence intervals (CI) using Stata SE 14 (metan command package). For dichotomous 
outcomes, we chose a conservative approach and used non-responder imputation in studies 
comparing to usual care. Continuous data was used as reported in the studies. We 
transformed standard errors into standard deviations. 
To avoid multiple testing errors, we focused on a limited number of outcomes (PASI, DLQI, 
otherwise the primary outcome). A random-effects meta-analysis was planned when more 
than one comparable study reported the same outcome. We considered I² as heterogeneity 
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statistic [25]. Sequential methods for meta-analysis will be used in the process of updating 
the review past June 2017 to avoid false positives due to multiple testing [26-28]. 
Additional evaluation using APEASE
Additionally, we used the APEASE criteria [29] to evaluate whether any of the identified 
interventions might be suitable for adaptation and further dissemination. We defined and 
operationalized the APEASE criteria as shown in Table 2. The operationalization of APEASE 
was discussed among the author team. Two authors (CD, MZ) evaluated each intervention 
independently.
[insert Table 2 here]
Results
We searched the academic databases on April 4th 2017, and grey literature repositories and 
the trial registry on March 20th 2017. The number of hits identified and the record selection 
process is displayed in Figure 2. We included 16 studies (current status: Dec 2017). Nine 
authors responded to our queries. Autoalerts are continuously being received and updates 
reported on http://spindermatology.org/Overview. 
[Insert Figure 2 here]
Included studies
We included eight RCTs [30-42], four CCTs [43-47] and four before and after studies [48-53]. 
The largest study included 1790 patients [30], the smallest 29 patients [34]. The mean ages 
of the patients were mid-forties to mid-fifties. Disease severity at inclusion differed among 
the studies. All but one study [40], which was identified via trial registry/grey literature 
searches, were found through academic databases searches. The characteristics of each 
intervention evaluated are displayed in Table S1 (online appendix).
Three further RCTs that were only available as abstracts [54-58]were excluded because the 
authors we contacted did not provide any further details on the studies   Three trials are 
ongoing (NCT02750800 and NCT02205593 and NCT03127462). An overview of the included 
studies can be found in Table S2 (see online appendix). Where sufficient data was reported, 
we calculated unadjusted effect measures and confidence intervals for each study (see text 
and figures 3a, 3b). Meta-analysis was not appropriate because the interventions described 
in the studies were so heterogeneous in design. 
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Two RCTs evaluated one-to-one interventions, one of which involved two main consultations 
[30, 31] and the other of which involved seven motivational interviewing sessions over 12 
weeks following climate therapy [32, 33]. Reich [30, 31] developed the Topical Treatment 
Optimization Programme to improve adherence in patients best treated with 
calcipotriol/betamethasone. Participants received two face-to-face consultations and an 
electronic reminder. Very small differences were seen after eight weeks in physician global 
assessment (RR 1.16, 95 % CI [1.02, 1.32] and DLQI (Figure 3a). In the second of these RCTs, 
Larsen [32, 33] offered seven sessions of motivational interviewing (MI) via telephone to 
patients who had participated in a three-week residential climate and heliotherapy program 
(CHT) in Gran Canaria. Discussions included skin treatment and lifestyle. Compared to usual 
care, a difference in favour of the intervention in the self-administered PASI (SAPASI) was 
seen three (MD -2.47, 95 %CI [-3.94, -1.00]) and six months after the intervention (MD -2.45, 
95 % CI [-4.33, -0.56]), as well as in the DLQI (Figure 3a). 
In another RCT, Bundy assessed an interactive web-based intervention for primary care 
patients with mild to moderate psoriasis [37, 38]. The program included six modules of 
cognitive-behavioral therapy (CBT), as well as interactive education activities. After six 
weeks, small differences were seen in DLQI (Figure 3a) and the Hospital Anxiety and 
Depression Scale (MD 2.00, 95 % CI [0.25, 3.75]). 
[insert Figure 3 here]
a) DLQI b) PASI
CL  confidence Interval
MD  mean difference 
TPE- therapeutic patient education intervention
UC  usual care
Figure 3: Mean differences for a) Dermatology Life Quality Index (DLQI) and b) Psoriasis 
Area and Severity Index (PASI) for each study (pooling was not appropriate due to the 
different study designs, intervention content and inclusion criteria)
Three RCTs reported group interventions that took place on several occasions. Bostoen [34-
36] evaluated a 12-week comprehensive educational and lifestyle program. Skin care 
sessions led by nurses, exercise and relaxation sessions were part of the program. There was 
no difference between the intervention and the control group after three, six or nine months 
(see Figure 3). Rothman [39] evaluated a three-week educational program. Patients were 
interviewed by a nurse to identify the precise challenges they faced. The resulting 
information was used to tailor the educational and functional interventions to each patient.. 
On the study-specific functional history chart (score 0-13, 13=worst) the intervention group 
scored a mean of 4.2 (n = 44) whereas the control group had a mean of 6.0 (n = 17, no 
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statistical test reported). Lastly, Thongkaow [40] compared self-help group instructions, 
which took place every four weeks, with usual care. Details of the intervention were not well 
reported. After 12 weeks, no difference in PASI between self-help group and standard 
clinical care were found (Figure 3b). 
Two further RCTs assessed short  group interventions. Educational nurse support was 
evaluated by Ersser [41]. A structured group learning experience and audiovisual learning 
materials were used. After six weeks, no difference was found in DLQI. For PASI, very small 
differences were seen (Figure 3). In the other RCT, ,  Lora [42] assessed whether a two-hour 
educational session for psoriasis patients delivered by a dermatologist was more effective 
than an identical one delivered by a dermatologist and a psychologist. Based on a study-
specific questionnaire, there was no clear pattern in terms of efficacy after six months. 
We included four CCTs. In the first of these, Bremer Schulte [43] developed the duo 
formula group therapy intervention whereby both the physician and the patient were 
trained to lead group sessions together. During ten two-hour sessions, emotions regarding 
psoriasis but also aspects of self-care, treatment options and the disease were discussed. 
After three months, the means of each equilibrium subscale (reduction of illness behaviour 
(IB), shame & shyness (SS), interactional skills (IS), problem solving (PSG), deidentification 
with skin (DS) and well-being (WB)) were significantly different to those measured in the 
control group for all but the last subscale. Improvements in psoriasis severity were not 
assessed. In the second CCT, Fortune [44, 45] reported the results of a cognitive behavioral 
management program that included teaching about medical and biological background of 
psoriasis. Six group sessions over six consecutive weeks took place. After six weeks, no 
difference was found between the groups (PASI MD -1.90, 95 % CI [-13.83, 10.03]). In the 
third CCT, Pagliarello [46] assessed the effectiveness of an empowerment-based educational 
intervention in addition to balneotherapy versus 12 days of balneotherapy alone. During one 
two-hour group workshop, psoriasis treatment options and modifiable risk factors were 
discussed. Before and after 12 days, the SAPASI, Skindex-17 and the PEER instrument were 
used to assess effects. However, the results were only reported as summary measures for all 
participants (see online appendix). In the fourth CCT, Renzi [47] conducted a quasi-
experiment in which, directly following consultations with their dermatologists, patients 
were presented with a visual overview of treatment options in the form of a so-called 
decision board to determine whether this had a positive effect on patient knowledge. 
Patients attitudes and satisfaction with the decision-making process did not differ between 
the groups. Knowledge appears to have increased slightly in the intervention group.
Lastly, we identified a total of four before and after studies. Burnett [48, 49] designed a five-
minute educational intervention that focused on possible cardiometabolic comorbidities, 
risk factors and risk reduction strategies specific to psoriasis. This face-to-face intervention 
was delivered by Burnett. Patients with moderate to severe psoriasis were eligible to 
participate. After two to three months, eight of the 11 study-specific questionnaire items 
were significantly different compared to baseline (online appendix, Table S2). De Korte [53] 
evaluated a disease management program in 10 medical centers in Europe. Three face-to-
face consultations over the period of two months were conducted with patients who 
received topical treatment. A comprehensive patient profile, disease management, 
education and goal setting tailored to patients needs were key parts of the program. The 
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Skindex-29 decreased and a self-assessed adherence measure increased by the end of the 
study period (online appendix, Table S2). Tucker [51] report an educational intervention 
whereby two face-to-face sessions took place in the pharmacy. The pharmacist had received 
a training package with information on psoriasis. Only patients who used topical treatments 
were eligible. The DLQI decreased from baseline to six weeks and the person-centered 
dermatology self-care index PEDESI increased (online appendix, Table S2). Finally, Wahl [50, 
52] reported a comprehensive educational intervention as part of a three-week climate 
therapy in Gran Canaria. Several individual and group sessions took place conducted by 
dermatologists, nurses and physiotherapists. Authors report that patients knowledge had 
improved (online appendix, Table S2). 
Study appraisal
Our evaluations -  based on self-reported results - were high due to non-blinding [30, 32, 
37, 42]47 and additionally due to missing data issues [34, 39], or lack of information [40] in 
the included RCTs. The risk of bias was subject to some concerns in the case of two studies 
that reported blinded outcome assessments [30, 41] . All other studies reporting blinded 
outcome assessments received an overall rating of high. We rated the risk of bias for the 
CCTs as being mostly moderate to serious, and one of the four before-after studies was 
rated as good (online appendix).
Additional evaluation using APEASE [29] 
While we were able to rate many of the interventions as affordable, practical and acceptable 
to patients, only three were effective. Of these three, one was not acceptable to patients, 
leaving two interventions that might be suitable for further dissemination (see Table 2 
above). Further investigations could be made regarding one intervention by de Korte as the 
quality was evaluated as good.
[Insert Table 3 here]
Discussion
We have been able to include 16 studies in this systematic review that meet our definition of 
TPE. The included studies differed greatly in terms of the content of the educational 
component, the delivery mode, the number and frequency of sessions, the type of 
professional who delivered the intervention, and whether the intervention was combined 
with another treatment. Furthermore, different patients were eligible for the interventions, 
such as those suitable for topical treatment [30, 41, 53] or with mild to moderate disease 
[37], mild to severe [42] or only moderate to severe disease severity [48] or those, who were 
either in- or outpatients [47].  The interventions were conducted in specific settings 
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including during or after climate therapy [32, 50], at the pharmacy [51], alongside primary 
care [37], at a day care facility [39] or at a spa [42, 46]. 
Only two multi-country interventions were included, all others were site-specific and 
content varied. The decision board for consultation [47] and the five-minute educational 
intervention [48] were the briefest interventions, whereas the web-based program was the 
most solitary (yet flexible) one [37] , whereas the group interventions were the most 
dynamic ones [34, 39, 40, 43, 44]. 
The majority of interventions can be classified as complex interventions [59]. The 
behavioural change techniques that were used in these studies were multi-faceted with 
active ingredients such as goal setting, feedback and monitoring, instructions and 
behavioural experiments or exercises, self-belief or social comparison (behaviour change 
taxonomy, [29]). In the figurative sense this matched the WHO definition of TPE (see Figure 
1), but apart from Reich [30], none of the publications described that participants were 
provided with information concerning how to better navigate the health care system or 
similar. Being able to navigate the health care system successfully is an important part of 
patient-centered care. 
Furthermore, for health care (systems) to be effective, adherence to long-term treatment is 
crucial, and self-management is an integral part of the care management cycle - the extent 
of this being the case varies greatly between systems/countries/regions. A chronic condition 
like psoriasis has to be managed long-term, sometimes for decades, and yet evidence on 
very long term TPE is lacking.. 
Of the interventions with comprehensively reported or calculable positive effects, three 
controlled studies included at least one individual session either face-to-face [30, 34] or via 
telephone [32] as well as two of the before-after studies [51, 53]. For many patients, the 
dermatologist remains the first source of information [60]. Perhaps at least an initial one-to-
one session with a health care professional (HCP) is influential. In that respect, there is still 
the risk that HCP assume a non-adherer does not want to take responsibility [61, 62]. Only 
two [43, 44] of four [40, 41] studies using group sessions as delivery mode were effective. 
For the remaining six studies, result or delivery mode were unclear. Better reporting quality 
is desirable. 
Three of five RCTs found small differences in DLQI, but the minimal necessary important 
difference, which has been defined as a different of four points from baseline [63], was 
neither seen in these three RCTs nor in the before-after study [51]. Due to non-blinding, our 
confidence in any patient-reported outcomes is limited.
Four of the eight RCTs/CCTs that used evidence or some sort of behavioural theory to design 
their intervention found an effect. However, none of them transparently described how the 
behavioural theory was operationalized.  Some aspects seem to be reflected in the type or 
content of the intervention. Research shows that interventions underpinned by theory tend 
to work better than those who are not [59]. 
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Implications for practice and research
Based on the APEASE evaluation, two programs  the topical treatment program (TTOP) and 
the motivational interviewing after climate therapy  appear suitable for real world 
implementation. Nevertheless, our risk of bias assessments suggest that the results of the 
studies reporting on these interventions should be treated with caution. However, we chose 
these programmes nevertheless, because in cases when patient-reported outcomes are 
measured, such as quality of life, studies will always receive a high risk of bias rating as it is 
usually likely to be influenced by the knowledge of the intervention, see Rob 2.0 guidance 
document [22, p.36]. Hence, we took a pragmatic stance and gave the RoB rating due to 
non-blinding less weight. 
Further inquiries should be made regarding the nurse-led intervention. While it was not 
found to be effective, modifications were suggested that might lead to improvements. . The 
same can be said of the web-based intervention, which was effective but suffered from too 
many drop outs. Generally, to support adaption, implementation and evaluation of an 
intervention to a new setting, extensive manuals on the development and the execution 
should be made available. 
Regarding further research, one included before-after study [53] was of good 
methodological quality and the intervention could be investigated further. It may also be 
worthwhile looking across medical specialties, since many self-management programs exist 
[64]. Several disease-independent factors such as those depending on the health care 
context interact in complex ways when it comes to program success and a broader look 
across disease and public health areas may be valuable before designing interventions. 
Limitations
The outcomes reported were heterogeneous, some wer  study-specific and some 
instruments not validated. We attempted to minimize reporting bias by choosing the 
primary outcome of the study if none of the pre-defined outcomes was reported. Although 
we cannot rule out the possibility of publication bias, we included grey literature repositories 
in our searches. Lastly, we took a pragmatic stance with APEASE, but we are  also the first 
researchers to transparently describe its use.
Conclusion 
There is some setting- and patient-specific evidence that TPE programs can have promising 
effects, but the internal validity of the studies in question is limited. Based on the results of 
our review and assessment using the APEASE criteria, we suggest that the topical treatment 
program (TTOP) [30] and motivational interviewing after climate therapy [32] may be 
suitable for adaptation to the real world setting. 
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Tables and Figures for main text
Table 1: modified PICOTS framework (including eligibility criteria)
 Inclusion Exclusion
Patient
- Psoriasis patients (at least 50% of the study 
population)
- Adults
- Psoriasis Arthritis
Intervention
Any therapeutic patient education 
intervention, or self-management support 
intervention with an interactive component 
and a TPE component (i.e. those with 
structured education activities that support 
patient-practitioner communication, self-
management, changes in life style or quality of 
life/psychosocial well-being)
- interventions that only 
raise awareness, for 
example, brochures 
without an interactive 
component
- pharmaceutical trials
Comparison
Another intervention, usual care, waiting list or 
no intervention, pharmaceutical intervention 
only
 - head-to-head drug trials
Outcome
Relevant parameters included: disease 
severity, symptom relief, patients self-
evaluated global/disease status, medication 
adherence, quality of life, self-efficacy, illness 
perception, psychological well-being
 -
Time/Setting
The setting is not limited to dermatology 
practices or specialized clinics; we also consider 
self-help groups, nurse-instigated 
interventions, or online tools as long as an 
interactive component was part of the 
intervention. 
We did not limit the 
timing. 
Study
The study design had to be a randomized 
controlled trial (RCT), a clinically controlled 
trial/quasi-experiment (CCT), or a before-after 
study. The aim here was to give a 
comprehensive overview of no only what is 
effective but also non-randomized designs that 
could be further investigated.
 
Other
-languages: English, German, French and 
Spanish
- due to funding limitations 
other languages had to be 
excluded
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Table 2: Definition and operationalization of APEASE criteria
APEASE Definition [29] Operationalization
Affordability Within an acceptable 
budget, the intervention 
can be delivered to, or 
accessed by all
direct costs for patients,
indirect costs for patients 
+ = Probably affordable
- = probably not affordable
? = no/missing information
Practicability Can the intervention be 
delivered as designed 
through the means 
intended to the target 
population?
Number/duration of sessions 
& staff and/or extra staff 
training required
- = many/long session and/or 
special material/intensive 
training for staff, specialty staff; 
+ = few/short sessions, no/little 
extra staff and training necessary
? = no/missing information
(cost) 
Effectiveness
Effect size in a real life 
situation
study effect sizes and 
confidence intervals
+ = effective1 (and cost effective)
-=  effective1 (and cost effective)
? = no/missing information
Acceptability Is an intervention judged 
to be appropriate by 
relevant stakeholders?
patient perspective only  
number of drop-outs during 
the intervention period
++ = < 1/5
+ =  < 1/ 4
- = < 1/3 
 -- = > = 1/3
? =no/ missing information
Safety Does an intervention have 
unwanted side effects?
Risk ratio or number of 
adverse events reported
- = yes/more in intervention 
group than control group/ 
+ = CI of RR crosses line of no 
effect, no/few events
? = no/missing information
Equity Does the intervention 
increase or decrease 
disparity / equity between 
people
Is it tailored to patients 
needs? 
+ = yes
- = no
? = no/missing information
1 more weight was given to the patient reported outcome
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Table 3: APEASE evaluation
Intervention 
(Author)
Affordability Practicability Effectiveness Acceptability Safety Equity
RCTs
Larsen* + + + ++ ? +
Reich* + + + ++ ? +
Bundy + + + - - ? +
Bostoen - - - ++ ? +
Rothmann - - ? - ? +
Thongkaow ? + - ? ? ?
Ersser + + - ++ ? +
Lora (only head-
to-head RCT)
+ + ? ? ? ?
CCTs
Bremer Schulte - - ? ? ? ?
Fortune + + - + ? +
Pagliarello + + ? ? ? ?
Renzi + + ? n/a ? ?
before-after
Burnett + + + ++ ? ?
De Korte + + + ++ ? +
Tucker + + + ++ ? +
Wahl - - + ++ ? ?
*suitable for adaptation and to be included in online dissemination toolbox 
grey: due to study design,results to be treated with caution
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Figure legends and table headings in main text
 
Order of Figures and Tables as they appear in the main text
1. Figure 1: Definition of Therapeutic Patient Education by the WHO
2. Table 1: modified PICOTS framework (including eligibility criteria)
3. Table 2: Definition and operationalization of APEASE criteria
4. Figure 2: Record selection flow chart
5. Figure 3a: Mean differences for Dermatology Life Quality Index; results per study 
(pooling was not appropriate due to the different study designs)
Legend for Figure 3a:
CL  confidence Interval
TPE- therapeutic patient education intervention
UC  usual care
MD  mean difference 
6. Figure 3b: Mean differences for Psoriasis Area and Severity Index; results per study 
(pooling was not appropriate due to the different study designs)
Legend for Figure 3b:
CL  confidence Interval
TPE- therapeutic patient education intervention
UC  usual care
MD  mean difference 
7. Table 3: Results of the APEASE evaluation
Legend for Table 3 :
 *suitable for adaptation and to be included in online dissemination toolbox 
grey: due to study design,results to be treated with caution 
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